Search Results - "Munch, Marie W."

Dexamethasone and Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia—Reply by Munch, Marie W, Granholm, Anders, Perner, Anders

Get full text

A new tool to assess Clinical Diversity In Meta‐analyses (CDIM) of interventions by Barbateskovic, Marija, Koster, Thijs M., Eck, Ruben J., Maagaard, Mathias, Afshari, Arash, Blokzijl, Fredrike, Cronhjort, Maria, Dieperink, Willem, Fabritius, Maria L., Feinberg, Josh, French, Craig, Gareb, Barzi, Geisler, Anja, Granholm, Anders, Hiemstra, Bart, Hu, Ruixue, Imberger, Georgina, Jensen, Bente T., Jonsson, Andreas B., Karam, Oliver, Kong, De Zhao, Korang, Steven K., Koster, Geert, Lai, Baoyong, Liang, Ning, Lundstrøm, Lars H., Marker, Søren, Meyhoff, Tine S., Nielsen, Emil E., Nørskov, Anders K., Munch, Marie W., Risom, Emilie C., Rygård, Sofie L., Safi, Sanam, Sethi, Naqash, Sjövall, Fredrik, Lauridsen, Susanne V., van Bakelen, Nico, Volbeda, Meint, van der Horst, Iwan C.C., Gluud, Christian, Perner, Anders, Møller, Morten H., Keus, Eric, Wetterslev, Jørn

“…To develop and validate Clinical Diversity In Meta-analyses (CDIM), a new tool for assessing clinical diversity between trials in meta-analyses of…”
Get full text

Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia: The COVID STEROID 2 Randomized Trial by Munch, Marie W, Myatra, Sheila N, Vijayaraghavan, Bharath Kumar Tirupakuzhi, Saseedharan, Sanjith, Benfield, Thomas, Wahlin, Rebecka R, Rasmussen, Bodil S, Andreasen, Anne Sofie, Poulsen, Lone M, Cioccari, Luca, Khan, Mohd S, Kapadia, Farhad, Divatia, Jigeeshu V, Brøchner, Anne C, Bestle, Morten H, Helleberg, Marie, Michelsen, Jens, Padmanaban, Ajay, Bose, Neeta, Møller, Anders, Borawake, Kapil, Kristiansen, Klaus T, Shukla, Urvi, Chew, Michelle S, Dixit, Subhal, Ulrik, Charlotte S, Amin, Pravin R, Chawla, Rajesh, Wamberg, Christian A, Shah, Mehul S, Darfelt, Iben S, Jørgensen, Vibeke L, Smitt, Margit, Granholm, Anders, Kjær, Maj-Brit N, Møller, Morten H, Meyhoff, Tine S, Vesterlund, Gitte K, Hammond, Naomi E, Micallef, Sharon, Bassi, Abhinav, John, Oommen, Jha, Anubhuti, Cronhjort, Maria, Jakob, Stephan M, Gluud, Christian, Lange, Theis, Kadam, Vaijayanti, Marcussen, Klaus V, Hollenberg, Jacob, Hedman, Anders, Nielsen, Henrik, Schjørring, Olav L, Jensen, Marie Q, Leistner, Jens W, Jonassen, Trine B, Kristensen, Camilla M, Clapp, Esben C, Hjortsø, Carl J. S, Jensen, Thomas S, Halstad, Liv S, Bak, Emilie R. B, Zaabalawi, Reem, Metcalf-Clausen, Matias, Abdi, Suhayb, Hatley, Emma V, Aksnes, Tobias S, Gleipner-Andersen, Emil, Alarcón, Arif F, Yamin, Gabriel, Heymowski, Adam, Berggren, Anton, La Cour, Kirstine, Weihe, Sarah, Pind, Alison H, Engstrøm, Janus, Jha, Vivekanand, Venkatesh, Balasubramanian, Perner, Anders

“…IMPORTANCE: A daily dose with 6 mg of dexamethasone is recommended for up to 10 days in patients with severe and critical COVID-19, but a higher dose may…”
Get full text

Dexamethasone and Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia/Dexamethasone and Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia/Dexamethasone and Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia/Dexamethasone and Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia-Reply by Zhao, Binghao, Ma, Wenbin, Zheng, Huanhuan, Bu, Shuangshan, Abouir, Kenza, Calmy, Alexandra, Lorenzini, Kuntheavy Roseline Ing, Munch, Marie W, Granholm, Anders, Perner, Anders

Get full text

Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia: The COVID STEROID 2 Randomized Trial (vol 326, pg 1807, 2021) by Munch, MW, Myatra, SN, Vijayaraghavan, BKT, Saseedharan, S, Benfield, T, Wahlin, RR, Rasmussen, BS, Andreasen, AS, Poulsen, LM, Cioccari, L

Get full text

Heterogeneity of treatment effect of higher dose dexamethasone by geographic region (Europe vs. India) in patients with COVID-19 and severe hypoxemia – a post hoc evaluation of the COVID STEROID 2 trial by Tirupakuzhi Vijayaraghavan, Bharath Kumar, Granholm, Anders, Myatra, Sheila N., Jha, Vivekanand, Hammond, Naomi, Micallef, Sharon, Munch, Marie Warrer, Kjær, Maj-Brit N., Møller, Morten Hylander, Lange, Theis, Perner, Anders, Venkatesh, Balasubramanian, Munch, Marie W., Myatra, Sheila N., Tirupakuzhi Vijayaraghavan, Bharath Kumar, Saseedharan, Sanjith, Benfield, Thomas, Wahlin, Rebecka R., Rasmussen, Bodil S., Andreasen, Anne Sofie, Poulsen, Lone M., Cioccari, Luca, Khan, Mohd S., Kapadia, Farhad, Divatia, Jigeeshu V., Brøchner, Anne C., Bestle, Morten H., Helleberg, Marie, Michelsen, Jens, Padmanaban, Ajay, Bose, Neeta, Møller, Anders, Borawake, Kapil, Kristiansen, Klaus T., Shukla, Urvi, Chew, Michelle S., Dixit, Subhal, Ulrik, Charlotte S., Amin, Pravin R., Chawla, Rajesh, Wamberg, Christian A., Shah, Mehul S., Darfelt, Iben S., Jørgensen, Vibeke L., Smitt, Margit, Granholm, Anders, Kjær, Maj-Brit N., Møller, Morten H., Meyhoff, Tine S., Vesterlund, Gitte K., Hammond, Naomi E., Micallef, Sharon, Bassi, Abhinav, John, Oommen, Jha, Anubhuti, Cronhjort, Maria, Jakob, Stephan M., Gluud, Christian, Lange, Theis, Kadam, Vaijayanti, Marcussen, Klaus V., Hollenberg, Jacob, Hedman, Anders, Nielsen, Henrik, Schjørring, Olav L., Jensen, Marie Q., Leistner, Jens W., Jonassen, Trine B., Kristensen, Camilla M., Clapp, Esben C., Hjortsø, Carl J.S., Jensen, Thomas S., Halstad, Liv S., Bak, Emilie R.B., Zaabalawi, Reem, Metcalf-Clausen, Matias, Abdi, Suhayb, Hatley, Emma V., Aksnes, Tobias S., Gleipner-Andersen, Emil, Alarcón, A.Felix, Yamin, Gabriel, Heymowski, Adam, Berggren, Anton, la Cour, Kirstine, Weihe, Sarah, Pind, Alison H., Engstrøm, Janus, Jha, Vivekanand, Venkatesh, Balasubramanian, Perner, Anders

“…In the COVID-STEROID 2 trial there was suggestion of heterogeneity of treatment effects (HTE) between patients enrolled from Europe vs. India on the primary…”
Get full text